Get started
MARINUS PHARMAC. DL-,001MARINUS PHARMAC. DL-,001MARINUS PHARMAC. DL-,001

MARINUS PHARMAC. DL-,001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

61Y chart


Full chart

61Y upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪28.78 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.215 EUR
Net income (FY)
‪−128.11 M‬ EUR
Revenue (FY)
‪28.08 M‬ EUR
Shares float
‪41.89 M‬
Beta (1Y)
3.79

About Marinus Pharmaceuticals, Inc.


Sector
Health Technology
CEO
Scott N. Braunstein
Headquarters
Radnor
Website
marinuspharma.com
Founded
2003
FIGI
BBG009DFGJ30
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

61Y news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MARINUS PHARMAC. DL-,001 stocks are traded under the ticker 61Y.
We've gathered analysts' opinions on MARINUS PHARMAC. DL-,001 future price: according to them, 61Y price has a max estimate of 1.95 EUR and a min estimate of 0.29 EUR. Watch 61Y chart and read a more detailed MARINUS PHARMAC. DL-,001 stock forecast: see what analysts think of MARINUS PHARMAC. DL-,001 and suggest that you do with its stocks.
61Y reached its all-time high on Jul 9, 2021 with the price of 16.100 EUR, and its all-time low was 0.215 EUR and was reached on Dec 23, 2024. View more price dynamics on 61Y chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track MARINUS PHARMAC. DL-,001 financials in yearly and quarterly reports right on TradingView.
MARINUS PHARMAC. DL-,001 is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
61Y earnings for the last quarter are −0.38 EUR per share, whereas the estimation was −0.37 EUR resulting in a −2.64% surprise. The estimated earnings for the next quarter are −0.32 EUR per share. See more details about MARINUS PHARMAC. DL-,001 earnings.
MARINUS PHARMAC. DL-,001 revenue for the last quarter amounts to ‪7.67 M‬ EUR, despite the estimated figure of ‪8.46 M‬ EUR. In the next quarter, revenue is expected to reach ‪10.23 M‬ EUR.
61Y net income for the last quarter is ‪−21.76 M‬ EUR, while the quarter before that showed ‪−33.45 M‬ EUR of net income which accounts for 34.95% change. Track more MARINUS PHARMAC. DL-,001 financial stats to get the full picture.
No, 61Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 25, 2025, the company has 165.00 employees. See our rating of the largest employees — is MARINUS PHARMAC. DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARINUS PHARMAC. DL-,001 EBITDA is ‪−109.66 M‬ EUR, and current EBITDA margin is −422.52%. See more stats in MARINUS PHARMAC. DL-,001 financial statements.
Like other stocks, 61Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARINUS PHARMAC. DL-,001 stock right from TradingView charts — choose your broker and connect to your account.